CareDx shares have doubled in 2026. Will July 30 earnings support the surge?
CareDx reports Q2 results on July 30 as investors assess transplant testing growth, Medicare coverage clarity and the Naveris strategy.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Geneoscopy’s ColoSense Medicare win puts stool RNA testing into the colorectal screening mainstream
Medicare coverage gives ColoSense a bigger test: can stool RNA screening move from FDA approval to real colorectal cancer adoption?
Pharma & Biotech
Why Pacira BioSciences, Inc. is positioning EXPAREL as a cost-saving tool in Medicare surgery
Find out how Pacira BioSciences, Inc.’s EXPAREL data could reduce opioid use and surgical costs in Medicare patients.